Inventor · disambiguated record
Dmitry Borkin
Also filed as: BORKIN DMITRY
15 granted patents·6 pending applications·159 citations·filing 2014–2025
93Inventor score
Top patents by PatentIndex Score
21 records- 0196US11673898B2Substituted inhibitors of menin-MLL and methods of useKURA ONCOLOGY INC·Filed 2020·Granted Jun 13, 2023·6 cites·27 claims
- 0296US10781218B2Substituted inhibitors of menin-MLL and methods of useKURA ONCOLOGY INC·Filed 2017·Granted Sep 22, 2020·16 cites·20 claims
- 0396US10077271B2Methods and compositions for inhibiting the interaction of menin with MLL proteinsKURA ONCOLOGY INC·Filed 2017·Granted Sep 18, 2018·14 cites·18 claims
- 0495US9216993B2Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereofUNIV MICHIGAN·Filed 2014·Granted Dec 22, 2015·33 cites·54 claims
- 0594US9505781B2Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereofUNIV MICHIGAN REGENTS·Filed 2014·Granted Nov 29, 2016·16 cites·50 claims
- 0694US9505782B2Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereofUNIV MICHIGAN REGENTS·Filed 2015·Granted Nov 29, 2016·24 cites·26 claims
- 0793US10752639B2Bridged bicyclic inhibitors of menin-MLL and methods of useKURA ONCOLOGY INC·Filed 2017·Granted Aug 25, 2020·8 cites·14 claims
- 0892US10588907B2Methods and compositions for inhibiting the interaction of menin with MLL proteinsKURA ONCOLOGY INC·Filed 2016·Granted Mar 17, 2020·6 cites·1 claims
- 0992US10174041B2Methods and compositions for inhibiting the interaction of menin with MLL proteinsKURA ONCOLOGY INC·Filed 2018·Granted Jan 8, 2019·11 cites·24 claims
- 1092US10160769B2Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereofUNIV MICHIGAN REGENTS·Filed 2016·Granted Dec 25, 2018·10 cites·25 claims
- 1189US10246464B2Thienopyrimidine and thienopyridine compounds and methods of use thereofUNIV MICHIGAN REGENTS·Filed 2015·Granted Apr 2, 2019·9 cites·20 claims
- 1288US11542248B2Methods and compositions for inhibiting the interaction of menin with MLL proteinsKURA ONCOLOGY INC·Filed 2018·Granted Jan 3, 2023·4 cites·14 claims
- 1384US11555041B2Bridged bicyclic inhibitors of menin-MLL and methods of useKURA ONCOLOGY INC·Filed 2020·Granted Jan 17, 2023·1 cites·10 claims
- 1470USRE49687EThienopyrimidine and thienopyridine compounds and methods of use thereofUNIV MICHIGAN REGENTS·Filed 2015·Granted Oct 10, 2023·1 cites·25 claims
- 1568US2025304589A1Methods and compositions for inhibiting the interaction of menin with mll proteinsKURA ONCOLOGY INC·Filed 2025·Application pending·0 cites
- 1667US2025320225A1Substituted inhibitors of menin-mll and methods of useKURA ONCOLOGY INC·Filed 2025·Application pending·0 cites
- 1766US2025340566A1Bridged bicyclic inhibitors of menin-mll and methods of useKURA ONCOLOGY INC·Filed 2025·Application pending·0 cites
- 1864US2024245645A1Ash1l inhibitors and methods and treatment therewithUNIV MICHIGAN REGENTS·Filed 2024·Application pending·0 cites
- 1954US2025108119A1NOVEL STEROID PAYLOADS, STEROID LINKERS, ADCs CONTAINING AND USE THEREOFIMMUNEXT INC·Filed 2022·Application pending·0 cites
- 2051US11883381B2ASH1L inhibitors and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2017·Granted Jan 30, 2024·0 cites·13 claims
- 2151US2023310634A1Anti-human vista antibodies and use thereofIMMUNEXT INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dmitry Borkin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →